GE-RENEWABLE-ENERGY
13.2.2020 10:02:09 CET | Business Wire | Press release
GE Renewable Energy’s Grid Solutions business (NYSE-GE) has been awarded €2.2 million through the European Commission’s LIFE climate action program to help fund the development of a sulfur hexafluoride (SF6 )-free, 420 kiloVolt (kV) 63 kilo Amps (kA) gas-insulated substation (GIS) circuit-breaker.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200213005296/en/
The new circuit-breaker will rely on GE’s industry-leading “Green Gas for Grid”—or “g3” (pronounced “g- cubed”)—technology, resulting in the same high performance and compact size as a traditional SF6 -insulated circuit-breaker, but with a gas mass having more than a 99% reduced CO₂ equivalent value. Upon completion in 2022, the g3 circuit-breaker is expected to be the first SF6 -free 420 kV gas-insulated substation circuit-breaker in the world.
A circuit-breaker is protective equipment used to cut power in case of a problem on the grid. High-voltage 420-kV circuit-breakers are found at electrical substations on long-distance transmission networks.
Due to its strong insulating and arc-quenching properties, SF6 is widely used in substation equipment with the transmission industry accounting for approximately 80% of the world’s usage. Identified as the world’s most potent greenhouse gas by the 1997 Kyoto Protocol, SF6 is estimated to contribute 23,500 times more emissions than CO₂ if leaked and can remain in the atmosphere for up to 3,200 years.
“Our g3 technology is a game-changing alternative to SF6 for high-voltage equipment and is part of GE’s broader efforts to help the electric transmission and distribution industry reduce its greenhouse gas emissions,” said Vera Silva, Chief Technology Officer at GE’s Grid Solutions.
“Because 420 kV is the highest voltage level used in most European countries, a proven g3 –insulated 420 kV circuit-breaker will demonstrate that g3 technology can be applied to other high-voltage levels, as well as all other gas-insulated substation components, such as disconnectors, earthing switches, voltage transformers,” said Yannick Kieffel, Grid Solutions’ Materials and Eco Design Team Leader and Project Leader for the EU-funded g3 project.
Currently, GE offers the following g3 products: live tank circuit-breakers and gas-insulated substations up to 145 kV, gas-insulated lines up to 420 kV and instrument transformers up to 245 kV.
“This project is a great fit for our recent round of LIFE financial awards due to its potential impact on Europe’s transition to a more sustainable and low-carbon future,” said Angelo Salsi, LIFE Programme Head of Unit at the Executive Agency for Small and Medium-sized Enterprises (EASME). “The LIFE program is one of the most efficient and well known EU funding mechanisms that has supported nature, the environment and climate action for over 25 years. We look forward to the positive ripple effect this project will have across Europe over the next decade and beyond.”
For the full press release on the g3 EU-funded circuit-breaker project LIFE18 CCM/FR/001096 LIFE GRID , click here .
GE’s Grid Solutions
Grid Solutions, a GE Renewable Energy business, serves customers globally with over 17,000 employees in approximately 80 countries. Grid Solutions helps enable utilities and industry to effectively manage electricity from the point of generation to the point of consumption, helping to maximize the reliability, efficiency and resilience of the grid. https://www.gegridsolutions.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20200213005296/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE03428.2.2026 01:00:00 CET | Press release
IDE034 is a B7H3/PTK7 bispecific TOP1 ADC designed to target tumor cells expressing both B7H3 and PTK7 preferentially, and is being evaluated as monotherapy and in combination with IDEAYA’s PARG inhibitor IDE161. IDEAYA has dosed the first patient in its Phase 1 trial of IDE034, initially evaluating safety, tolerability, and PK. First dosing triggers a $5 million milestone payment to Biocytogen under the companies’ option and license agreement. Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that its partner IDEAYA Biosciences, Inc. (“IDEAYA”; Nasdaq: IDYA) has dosed the first patient in IDEAYA’s Phase 1 dose-escalation/expansion clinical trial of IDE034, an investigational B7H3/PTK7 bispecific TOP1 ADC. Pursuant to the companies’ option and license agreement, first patient dosing triggers a $5 million
IQM and Real Asset Acquisition Corp. to Host Conference Call/Webcast to Discuss Proposed Transaction27.2.2026 13:00:00 CET | Press release
IQM Finland Oy, a global leader in full-stack superconducting quantum computers (“IQM”, “IQM Quantum Computers” or the “Company”), and Real Asset Acquisition Corp. (Nasdaq: RAAQ), a special purpose acquisition company (“RAAQ”), announced that they will host a conference call to discuss their recently announced business combination, including certain transaction highlights. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260227472716/en/ IQM Radiance quantum computer As previously disclosed, on February 23, 2026, IQM and RAAQ announced they have entered into a definitive business combination agreement, which will result in IQM becoming a public company and listing American Depositary Shares on one of the two leading U.S. stock exchanges. The transaction provides funding with the aim to accelerate IQM’s technology and commercial development towards fault-tolerance quantum computing, further advancing its position as a leading p
HighRadius Launches $0 Implementation Fee, $0 Subscription Fee via Outcome Based Pricing for oCFO Software27.2.2026 12:00:00 CET | Press release
HighRadius launches Office of the CFO first Outcome Based Pricing with $0 Implementation fee and $0 Subscription until Go-Live. Customers only pay a fraction of realized gains based on P&L impact. Chapter 1: Outcome Based Pricing (OBP)Introduction of OBP: HighRadius, a provider of 190+ AI agents for Order-to-Cash, Accounts Payable, Record-to-Report, and Treasury introduces Outcome Based Pricing (OBP). Three Components of OBP: Customers pay a) $0 in Implementation fees, b) $0 in Subscription fees until Go Live, c) HighRadius earns a fraction of the actual savings realized by the client. Chapter 2: US GAAP & ASC 606 ConstraintsNot Designed for Innovation: The traditional ASC 606 model requires companies to standardize and recognize revenue based on contractual obligations. For a traditional SaaS subscription, the obligation is access to software over time. AI agents are designed to deliver quantifiable, real-time Business Outcomes that do not fit the traditional accounting framework. Cha
Kioxia Appoints Yoshihiko Kawamura as Chief Financial Officer27.2.2026 09:15:00 CET | Press release
Kioxia Holdings Corporation (TOKYO:285A), a world leader in memory solutions, today announced the appointment of Yoshihiko Kawamura as Chief Financial Officer (CFO), effective April 1, 2026. Mr. Kawamura brings extensive international experience to Kioxia, having held assignments at Mitsubishi Corporation’s U.S. headquarters, served as General Manager of its Chicago office, and completed a tenure at the World Bank. At Hitachi, Ltd., he held senior leadership positions, including Chief Strategy Officer (CSO), Chief Financial Officer (CFO), and Chief Risk Management Officer (CRMO), where he was instrumental in leading the company’s management reforms. Since joining Kioxia as Executive Vice President in June 2025, Mr. Kawamura has worked closely with the executive team to advance the business through strategic capital and financial planning. Following its initial public offering on the Prime Market of the Tokyo Stock Exchange in December 2024, Kioxia is entering a new phase of growth char
DNP Invests in Rapidus to Support the Establishment of Mass Production for Next-Generation Semiconductors27.2.2026 08:18:00 CET | Press release
Will accelerate the development and mass production of EUV lithography photomasks Dai Nippon Printing Co., Ltd. (DNP, TOKYO:7912) today announced that it has participated in Rapidus Corporation’s funding round as one of the round investors. This strategic funding initiative supports Rapidus’ plan to steadily progress from its current R&D phase to mass production of 2nm (10⁻⁹ meters) logic semiconductors by 2027. Through this initiative, DNP will advance the development and mass production of EUV lithography photomasks and support Rapidus as it establishes a mass production system for 2nm & next-generation semiconductors. Background In recent years, the rise in energy consumption, in line with increased data generation, has become a challenge, driving demand for next-generation semiconductors capable of improving device performance and reducing power consumption. Next-generation semiconductors manufactured using EUV lithography enable the formation of finer patterns on silicon wafers co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom